Navigation Links
Smith & Nephew Endoscopy Awarded $85 Million in Patent Infringement Case Against Arthrex, Inc.
Date:6/23/2011

ANDOVER, Mass., June 23, 2011 /PRNewswire/ -- Smith & Nephew, Inc., Endoscopy Division, a subsidiary of Smith & Nephew plc (NYSE: SNN) (London Stock Exchange: SN) announced today that the jury in United States District Court in Oregon found in Smith & Nephew's favor that Arthrex, Inc., (Naples, Fla.) was guilty of infringing U.S. Patent 5,601,557, which is exclusively licensed to Smith & Nephew.

The jury found that Arthrex's Bio-SutureTak, PEEK SutureTak, PushLock and Bio-PushLock suture anchors infringe the patent and awarded Smith & Nephew $85 million for Arthrex's past infringement activities.

This is the second time Smith & Nephew won this patent infringement case in the Oregon Court.  In June 2008, a jury decided that Arthrex willfully infringed the same asserted patent.  At that time the jury awarded Smith & Nephew $14.7 million for past infringement.  In November 2009, the Court of Appeals for the Federal Circuit revised the interpretation of a term in the patent and sent the case back to the Oregon court for a new trial based on that revised claim interpretation.  

Contact:
Media
Joe Metzger
SVP, Corporate Communications
Smith & Nephew Endoscopy
(978) 749-1330
joe.metzger@smith-nephew.com

Investor/Analyst
Phil Cowdy
Head of Corporate Affairs
Smith & Nephew
44 (0)20 7401 7646

About Smith & Nephew

Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy, including Sports Medicine; and Advanced Wound Management.  Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orth
'/>"/>

SOURCE Smith & Nephew, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
9. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
10. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
11. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)...  Express Scripts (NASDAQ: ESRX ) today ... Medicare ® Prescription Drug Plans (PDP) will offer ... WAG ) (NASDAQ: WAG ), helping ...  for their Medicare dollars. Medicare beneficiaries who ... or Choice plans for 2015 can save ...
(Date:10/1/2014)... , Oct. 1, 2014   Royal ... PHIA) today announced its eCareCoordinator and eCareCompanion telehealth ... Food and Drug Administration (FDA). A part of ... programs , eCareCoordinator and eCareCompanion are focused on ... first clinical applications to be available through the ...
(Date:10/1/2014)... 2014 Ardelyx, Inc. (NASDAQ: ... focused on cardio-renal, gastrointestinal and metabolic diseases, ... patient Phase 2b clinical trial evaluating tenapanor ... (IBS-C).  Results from this study demonstrated statistically ... symptoms for tenapanor-treated patients compared to patients ...
Breaking Medicine Technology:Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 3Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 4Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6
... Colo., Dec. 19, 2011   LABS, Inc., a global, ... expertise in regulated testing for human organs, cells, tissues ... named Company of the Year by the 2011 Colorado ... and honors individuals and companies that have made a ...
... Accuray Incorporated (Nasdaq: ARAY ), the ... medical centers globally have installed both a CyberKnife ... System enabling the delivery of personalized treatment for the ... smaller community sites in rural areas, mid-sized regional hospitals ...
Cached Medicine Technology:LABS, Inc. Named Colorado's Bioscience Company of the Year 2LABS, Inc. Named Colorado's Bioscience Company of the Year 3Medical Centers Worldwide Adopt Both Accuray's CyberKnife and TomoTherapy Systems 2Medical Centers Worldwide Adopt Both Accuray's CyberKnife and TomoTherapy Systems 3Medical Centers Worldwide Adopt Both Accuray's CyberKnife and TomoTherapy Systems 4
(Date:10/1/2014)... Journal of the American Medical Association shows ... or severe chronic knee pain, acupuncture did not provide ... randomly assigned 282 patients (50 years or older) with ... pretend laser treatment. , Treatments were delivered for ... and sham (inactive) laser acupuncture. , Researcher Professor Kim ...
(Date:10/1/2014)... New research suggests the adage that encourages people to ... target when it comes to exercise. When walking, staying ... distance to it appear shorter and help people walk ... compares this technique to walking while looking around the ... quality of exercise. , "People are less interested in ...
(Date:10/1/2014)... Lifeinsurance-policy.com has released a new blog post explaining how ... , Smoking will always have a negative impact on ... method to find affordable coverage. Insurance brokerage websites specialize ... , Whole life insurance premiums will be fixed throughout ... is permanent, the initial rates are very important. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Join the more ... Eating Disorder Treatment Center’s first ever charity golf tournament to ... people with eating disorders who cannot afford treatment. The tournament ... Club in Eureka, Mo. , The day-long event starts ... A reception and award dinner will begin at 5 p.m. ...
(Date:10/1/2014)... 01, 2014 Diet Doc understands that many ... lose weight and their dieting attempts could be easily sabotaged ... hormone diet treatments into their programs as a ... see fast and effective weight loss results, it also allows ... habits to maintain their weight for the future. , Earlier ...
Breaking Medicine News(10 mins):Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4
... United Kingdom and hires Michael Dyson to run European operations. ... ... DNA2.0, the leading gene synthesis and protein engineering company, today announced ... the United Kingdom-based DNA2.0 Ltd. Michael Dyson, PhD, has been appointed ...
... May help avoid incorrect Breast Cancer diagnosis and management ... 10 /PRNewswire-FirstCall/ - Predictive medicine company PreMD Inc. (TSX: ... provisional patent application that describes a new simplified method ... application was filed with the United States Patent and ...
... 10 Prime Therapeutics LLC (Prime),announces that it has ... Montana,(BCBSMT) to provide commercial pharmacy benefit management services, beginning,January ... Prime will provide pharmacy benefit services to more than ... drug coverage. The,three-year contract covers a range of pharmacy ...
... these medications may be reason, study suggests , , TUESDAY, ... prescription drugs, primarily pain relievers, appear to be ... suggests. , West Virginia, in particular, has seen a ... who have uncovered patterns of "doctor shopping" for drugs ...
... Award-Winning Recording Artist Toni Braxton and Her Son Featured in ... NEW YORK, Dec. 10 The Advertising Council, in ... new series of public service advertisements (PSAs) featuring Grammy award-winning ... raise awareness about autism and to urge parents to learn ...
... be faced with a national health care crisis in the ... a growing number of older adults find themselves diagnosed with ... of a team of researchers from across the country who ... older patients at risk of or dealing with cancer are ...
Cached Medicine News:Health News:DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations 2Health News:PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers 2Health News:PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers 3Health News:Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client 2Health News:Painkillers Linked to Increase in Overdose Deaths 2Health News:Painkillers Linked to Increase in Overdose Deaths 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 4Health News:Surge in older cancer survivors expected as baby boomers age 2Health News:Surge in older cancer survivors expected as baby boomers age 3
... an interventional guidance device that uses ... the accuracy of computed tomography (CT)-guided ... accuracy, SimpliCT® also has the potential ... puncture procedures including biopsies and fluid ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
... QuadraLase™ is a unique ... cap that may be rotated ... positions: like having four fibers ... be used for vaporization and ...
... the first truly lateral, all quartz fiber. ... (NA) compression technology for Total Internal Reflection ... The resulting output is virtually indistinguishable from ... transmission efficiency in a round spot of ...
Medicine Products: